1004981-53-6

Basic information

• Product Name: 5-((2R,3R)-5,7-diacetoxy-3-((3,5-diacetoxy-4-methoxybenzoyl)oxy)chroman-2-yl)-benzene-1,2,3-triyl triacetate
• Synonyms: 5-((2R,3R)-5,7-diacetoxy-3-((3,5-diacetoxy-4-methoxybenzoyl)oxy)chroman-2-yl)-benzene-1,2,3-triyl triacetate
• CAS NO: 1004981-53-6
• Molecular Weight: 766.666
• Mol File: 1004981-53-6.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 5-((2R,3R)-5,7-diacetoxy-3-((3,5-diacetoxy-4-methoxybenzoyl)oxy)chroman-2-yl)-benzene-1,2,3-triyl triacetate(CAS DataBase Reference)
• NIST Chemistry Reference: 5-((2R,3R)-5,7-diacetoxy-3-((3,5-diacetoxy-4-methoxybenzoyl)oxy)chroman-2-yl)-benzene-1,2,3-triyl triacetate(1004981-53-6)
• EPA Substance Registry System: 5-((2R,3R)-5,7-diacetoxy-3-((3,5-diacetoxy-4-methoxybenzoyl)oxy)chroman-2-yl)-benzene-1,2,3-triyl triacetate(1004981-53-6)

Safety Data

• Hazardous Substances Data: 1004981-53-6(Hazardous Substances Data)

Upstream product

• 74-88-4 methyl iodide 
• 148707-39-5 (-)-epigallocatechin 3-O-galloylperacetate 
• 2596-50-1 (-)-epigallocathechin gallate 

Downstream Products

• 224434-07-5 (-)-(2R,3R)-5,7-bis(hydroxy)-2-(3,4,5-tris(hydroxy)phenyl)chroman-3-yl-(3,5-bisbenzyloxy-4-methoxy)benzoate 

Relevant articles and documents

Facile synthesis of 4″-O-alkyl-(–)-EGCG derivatives through regioselective deacetylative alkylation

Therapeutic potential of the D-ring methyl ethers of (–)-epigallocatechin-3-gallate [(–)-EGCG] warrants extensive structure–activity relationship study of various D-ring ethers of (–)-EGCG but, for this purpose, efficient synthetic strategy needs to be de

Synthesis of phosphates and phosphates-acetates hybrids of green tea polyphenol (-)-epigallocatechine-3-gallate (EGCG) and its G ring deoxy analogs as potential anticancer prodrugs

A series of phosphate or phosphate-acetate hybrid modified EGCG or EGCG G ring deoxy analogs were synthesized by a convenient semi-synthesis strategy from the abundant natural compound EGCG.